【原美源伯根】Cencora (COR) 2021年年度报告「NYSE」.pdf

1、2021 Summary Annual Report2About AmerisourceBergen3AmerisourceBergen04 About AmerisourceBergen07 CEO statement20 Financial highlights22 Management team23 Board of Directors24 GAAP/Non-GAAP financial measures26 Corporate information4About AmerisourceBergenAmerisourceBergen is one of the largest globa

2、l pharmaceutical sourcing and distribution services companies,helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care.With services ranging from drug distribution and niche premium logistics to reimbursement and pharm

3、aceutical consulting services,AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.With over$200 billion in annual revenue,AmerisourceBergen is headquartered in Conshohocken,PA,and employs approximately 42,000 people around

4、the world.AmerisourceBergen is ranked#8 on the Fortune 500 list.We distribute a comprehensive offering of brand name and generic pharmaceuticals including specialty pharmaceutical products,over-the-counter healthcare products,home healthcare supplies and equipment and related services to a wide vari

5、ety of healthcare providers located in the United States,Europe,and select global markets.Our customers include chain retail and independent pharmacies,mail order pharmacies,acute care hospitals and health systems,physician practices,medical and dialysis clinics,long-term care and other alternate si

6、te pharmacies,veterinarians,and others.Additionally,we furnish healthcare providers and pharmaceutical manufacturers with an assortment of related high-value services,including reimbursement and pharmaceutical consulting services,niche premium logistics services,inventory management,pharmacy automat